-
Something wrong with this record ?
Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload
K. Pimková, L. Chrastinová, J. Suttnar, J. Štikarová, R. Kotlín, J. Čermák, JE. Dyr,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2008
PubMed Central
from 2008
Europe PubMed Central
from 2008
ProQuest Central
from 2014-01-01
Open Access Digital Library
from 2008-01-01
Open Access Digital Library
from 2008-01-01
Open Access Digital Library
from 2009-01-01
Medline Complete (EBSCOhost)
from 2011-01-01
Health & Medicine (ProQuest)
from 2014-01-01
Wiley-Blackwell Open Access Titles
from 2008
PubMed
24669287
DOI
10.1155/2014/416028
Knihovny.cz E-resources
- MeSH
- Dipeptides blood MeSH
- Nitrates blood MeSH
- Nitrites blood MeSH
- Ferritins blood MeSH
- Humans MeSH
- Malondialdehyde blood MeSH
- Myelodysplastic Syndromes blood complications pathology MeSH
- Oxidation-Reduction MeSH
- Oxidative Stress MeSH
- Iron Overload blood complications pathology MeSH
- Case-Control Studies MeSH
- Sulfhydryl Compounds blood MeSH
- Treatment Outcome MeSH
- Iron blood MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The role of oxidative stress in the initiation and progression of myelodysplastic syndromes (MDS) as a consequence of iron overload remains unclear. In this study we have simultaneously quantified plasma low-molecular-weight aminothiols, malondialdehyde, nitrite, and nitrate and have studied their correlation with serum iron/ferritin levels, patient treatment (chelation therapy), and clinical outcomes. We found significantly elevated plasma levels of total, oxidized, and reduced forms of cysteine (P < 0.001), homocysteine (P < 0.001), and cysteinylglycine (P < 0.006) and significantly depressed levels of total and oxidized forms of glutathione (P < 0.03) and nitrite (P < 0.001) in MDS patients compared to healthy donors. Moreover, total (P < 0.032) and oxidized cysteinylglycine (P = 0.029) and nitrite (P = 0.021) differed significantly between the analyzed MDS subgroups with different clinical classifications. Malondialdehyde levels in plasma correlated moderately with both serum ferritin levels (r = 0.78, P = 0.001) and serum free iron levels (r = 0.60, P = 0.001) and were significantly higher in patients with iron overload. The other analyzed compounds lacked correlation with iron overload (represented by serum iron/ferritin levels). For the first time our results have revealed significant differences in the concentrations of plasma aminothiols in MDS patients, when compared to healthy donors. We found no correlation of these parameters with iron overload and suggest the role of oxidative stress in the development of MDS disease.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008161
- 003
- CZ-PrNML
- 005
- 20150331111904.0
- 007
- ta
- 008
- 150306s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2014/416028 $2 doi
- 035 __
- $a (PubMed)24669287
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pimková, Kristýna $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic.
- 245 10
- $a Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload / $c K. Pimková, L. Chrastinová, J. Suttnar, J. Štikarová, R. Kotlín, J. Čermák, JE. Dyr,
- 520 9_
- $a The role of oxidative stress in the initiation and progression of myelodysplastic syndromes (MDS) as a consequence of iron overload remains unclear. In this study we have simultaneously quantified plasma low-molecular-weight aminothiols, malondialdehyde, nitrite, and nitrate and have studied their correlation with serum iron/ferritin levels, patient treatment (chelation therapy), and clinical outcomes. We found significantly elevated plasma levels of total, oxidized, and reduced forms of cysteine (P < 0.001), homocysteine (P < 0.001), and cysteinylglycine (P < 0.006) and significantly depressed levels of total and oxidized forms of glutathione (P < 0.03) and nitrite (P < 0.001) in MDS patients compared to healthy donors. Moreover, total (P < 0.032) and oxidized cysteinylglycine (P = 0.029) and nitrite (P = 0.021) differed significantly between the analyzed MDS subgroups with different clinical classifications. Malondialdehyde levels in plasma correlated moderately with both serum ferritin levels (r = 0.78, P = 0.001) and serum free iron levels (r = 0.60, P = 0.001) and were significantly higher in patients with iron overload. The other analyzed compounds lacked correlation with iron overload (represented by serum iron/ferritin levels). For the first time our results have revealed significant differences in the concentrations of plasma aminothiols in MDS patients, when compared to healthy donors. We found no correlation of these parameters with iron overload and suggest the role of oxidative stress in the development of MDS disease.
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a dipeptidy $x krev $7 D004151
- 650 _2
- $a ferritiny $x krev $7 D005293
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a železo $x krev $7 D007501
- 650 _2
- $a přetížení železem $x krev $x komplikace $x patologie $7 D019190
- 650 _2
- $a malondialdehyd $x krev $7 D008315
- 650 _2
- $a myelodysplastické syndromy $x krev $x komplikace $x patologie $7 D009190
- 650 _2
- $a dusičnany $x krev $7 D009566
- 650 _2
- $a dusitany $x krev $7 D009573
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a sulfhydrylové sloučeniny $x krev $7 D013438
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Chrastinová, Leona $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic.
- 700 1_
- $a Suttnar, Jiří $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic.
- 700 1_
- $a Štikarová, Jana $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic.
- 700 1_
- $a Kotlín, Roman $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic.
- 700 1_
- $a Čermák, Jaroslav $u Clinical Department, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic.
- 700 1_
- $a Dyr, Jan Evangelista $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic.
- 773 0_
- $w MED00180520 $t Oxidative medicine and cellular longevity $x 1942-0994 $g Roč. 2014, č. - (2014), s. 416028
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24669287 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150331112134 $b ABA008
- 999 __
- $a ok $b bmc $g 1065434 $s 890961
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 2014 $c - $d 416028 $i 1942-0994 $m Oxidative medicine and cellular longevity $n Oxid Med Cell Longev $x MED00180520
- LZP __
- $a Pubmed-20150306